Search Results

There are 7365 results for: content related to: Pharmacogenetics of cutaneous adverse drug reactions

  1. You have free access to this content
    Association between HLA and Stevens–Johnson Syndrome Induced by Carbamazepine in Southern Han Chinese: Genetic Markers besides B*1502?

    Basic & Clinical Pharmacology & Toxicology

    Volume 111, Issue 1, July 2012, Pages: 58–64, Yi-Wu Shi, Fu-Li Min, Bin Qin, Xin Zou, Xiao-Rong Liu, Mei-Mei Gao, Qian Wang, Jue-Qian Zhou and Wei-Ping Liao

    Article first published online : 17 MAR 2012, DOI: 10.1111/j.1742-7843.2012.00868.x

  2. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions

    Epilepsia

    Volume 55, Issue 4, April 2014, Pages: 496–506, Ursula Amstutz, Neil H. Shear, Michael J. Rieder, Soomi Hwang, Vincent Fung, Hidefumi Nakamura, Mary B. Connolly, Shinya Ito, Bruce C. Carleton and the CPNDS clinical recommendation group

    Article first published online : 5 MAR 2014, DOI: 10.1111/epi.12564

  3. You have free access to this content
    HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese

    Epilepsia

    Volume 54, Issue 7, July 2013, Pages: 1307–1314, Ying-Kit Cheung, Suk-Hang Cheng, Ernest J. M. Chan, Su V. Lo, Margaret H. L. Ng and Patrick Kwan

    Article first published online : 20 MAY 2013, DOI: 10.1111/epi.12217

  4. Association of HLA-B*1502 allele with lamotrigine-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis

    International Journal of Dermatology

    Tao Zeng, Yue-Sheng Long, Fu-Li Min, Wei-Ping Liao and Yi-Wu Shi

    Article first published online : 27 NOV 2014, DOI: 10.1111/ijd.12570

  5. HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain

    Pain Practice

    Volume 12, Issue 3, March 2012, Pages: 202–208, Kongkiat Kulkantrakorn, Wichittra Tassaneeyakul, Somsak Tiamkao, Thawinee Jantararoungtong, Napat Prabmechai, Suda Vannaprasaht, Pansu Chumworathayi, Pei Chen and Paskorn Sritipsukho

    Article first published online : 16 JUN 2011, DOI: 10.1111/j.1533-2500.2011.00479.x

  6. You have free access to this content
    Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand

    Epilepsia

    Volume 54, Issue 9, September 2013, Pages: 1628–1638, Waranya Rattanavipapong, Tanunya Koopitakkajorn, Naiyana Praditsitthikorn, Surakameth Mahasirimongkol and Yot Teerawattananon

    Article first published online : 29 JUL 2013, DOI: 10.1111/epi.12325

  7. HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis

    Epilepsia

    Volume 55, Issue 11, November 2014, Pages: e120–e124, Amy Hui-Ping Khor, Kheng-Seang Lim, Chong-Tin Tan, Su-Ming Wong and Ching-Ching Ng

    Article first published online : 29 SEP 2014, DOI: 10.1111/epi.12802

  8. You have free access to this content
    HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

    Epilepsia

    Volume 51, Issue 12, December 2010, Pages: 2461–2465, Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara, Kayoko Matsunaga, Masahiro Tohkin, Kouichi Kurose, Hirokazu Furuya, Yukitoshi Takahashi, Masaaki Muramatsu, Shigeru Kinoshita, Masamichi Abe, Hiroko Ikeda, Mariko Kashiwagi, Yixuan Song, Mayumi Ueta, Chie Sotozono, Zenro Ikezawa, Ryuichi Hasegawa and for the JSAR research group

    Article first published online : 3 NOV 2010, DOI: 10.1111/j.1528-1167.2010.02766.x

  9. Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing

    Clinical Pharmacology & Therapeutics

    Volume 94, Issue 3, September 2013, Pages: 324–328, S G Leckband, J R Kelsoe, H M Dunnenberger, A L George Jr, E Tran, R Berger, D J Müller, M Whirl-Carrillo, K E Caudle and M Pirmohamed

    Article first published online : 21 MAY 2013, DOI: 10.1038/clpt.2013.103

  10. You have free access to this content
    Clinical risk management of Stevens–Johnson syndrome/toxic epidermal necrolysis spectrum

    Dermatologic Therapy

    Volume 22, Issue 5, September/October 2009, Pages: 441–451, Sandra Knowles and Neil H. Shear

    Article first published online : 1 SEP 2009, DOI: 10.1111/j.1529-8019.2009.01260.x

  11. You have free access to this content
    Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population

    Epilepsia

    Volume 51, Issue 5, May 2010, Pages: 926–930, Wichittra Tassaneeyakul, Somsak Tiamkao, Thawinee Jantararoungtong, Pei Chen, Shu-Yi Lin, Wei-Hsuan Chen, Parinya Konyoung, Usanee Khunarkornsiri, Narong Auvichayapat, Kasemsin Pavakul, Kongkiat Kulkantrakorn, Charoen Choonhakarn, Siranun Phonhiamhan, Namfon Piyatrakul, Thiti Aungaree, Sunsanee Pongpakdee and Praphan Yodnopaglaw

    Article first published online : 19 MAR 2010, DOI: 10.1111/j.1528-1167.2010.02533.x

  12. Pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens–Johnson syndrome: a critical appraisal

    British Journal of Dermatology

    Volume 166, Issue 1, January 2012, Pages: 7–11, K. Wu and N.J. Reynolds

    Article first published online : 27 DEC 2011, DOI: 10.1111/j.1365-2133.2011.10754.x

  13. HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

    Clinical Pharmacology & Therapeutics

    Volume 94, Issue 1, July 2013, Pages: 142–149, U Amstutz, C J D Ross, L I Castro-Pastrana, M J Rieder, N H Shear, M R Hayden, B C Carleton and CPNDS Consortium

    Article first published online : 18 MAR 2013, DOI: 10.1038/clpt.2013.55

  14. You have free access to this content
    Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population

    Epilepsia

    Volume 49, Issue 12, December 2008, Pages: 2087–2091, Chaichon Locharernkul, Jakrin Loplumlert, Chusak Limotai, Wiwat Korkij, Tayard Desudchit, Siraprapa Tongkobpetch, Oratai Kangwanshiratada, Nattiya Hirankarn, Kanya Suphapeetiporn and Vorasuk Shotelersuk

    Article first published online : 14 JUL 2008, DOI: 10.1111/j.1528-1167.2008.01719.x

    Corrected by:

    ERRATA

    Vol. 50, Issue 4, 971, Article first published online: 3 APR 2009

  15. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 3, March 2013, Pages: 356–364, Y.-T. Lin, Y.-C. Chang, R.C.-Y. Hui, C.-H. Yang, H.-C. Ho, S.-I. Hung and W.-H. Chung

    Article first published online : 3 JAN 2012, DOI: 10.1111/j.1468-3083.2011.04418.x

  16. You have free access to this content
    Immunological response in Stevens–Johnson syndrome and toxic epidermal necrolysis

    The Journal of Dermatology

    Volume 42, Issue 1, January 2015, Pages: 42–48, Riichiro Abe

    Article first published online : 30 OCT 2014, DOI: 10.1111/1346-8138.12674

  17. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens–Johnson syndrome in the multi-ethnic Malaysian population

    International Journal of Dermatology

    Volume 50, Issue 2, February 2011, Pages: 221–224, Choong-Chor Chang, Chun-Lai Too, Shahnaz Murad and Suraiya Hani Hussein

    Article first published online : 19 JAN 2011, DOI: 10.1111/j.1365-4632.2010.04745.x

  18. You have free access to this content
    Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA

    Allergy

    Volume 67, Issue 11, November 2012, Pages: 1338–1346, J. Yun, J. Adam, D. Yerly and W. J. Pichler

    Article first published online : 3 SEP 2012, DOI: 10.1111/all.12008

  19. You have free access to this content
    HLA-B Alleles and Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Han Chinese Population

    Basic & Clinical Pharmacology & Toxicology

    Volume 109, Issue 1, July 2011, Pages: 42–46, Yi-Wu Shi, Fu-Li Min, Xiao-Rong Liu, Li-Xuan Zan, Mei-Mei Gao, Mei-Juan Yu and Wei-Ping Liao

    Article first published online : 16 MAR 2011, DOI: 10.1111/j.1742-7843.2011.00681.x

  20. You have free access to this content
    HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens–Johnson syndrome/toxic epidermal necrolysis in a Portuguese population

    British Journal of Dermatology

    Volume 169, Issue 3, September 2013, Pages: 660–665, M. Gonçalo, I. Coutinho, V. Teixeira, A.R. Gameiro, M.M. Brites, R. Nunes and A. Martinho

    Article first published online : 30 AUG 2013, DOI: 10.1111/bjd.12389